Report error Found 23 Enz. Inhib. hit(s) with all data for entry = 12693
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 10nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 10nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 10nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 10nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 10nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 10nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 10nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 10nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 10nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 10nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 10nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 30nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 30nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 30nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 30nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 30nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 30nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 30nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 30nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 30nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 30nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 30nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
TargetSon of sevenless homolog 1(Human)
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
US Patent
Affinity DataIC50: 200nMAssay Description:Test compounds were dissolved in DMSO, and 10-point serial 3-fold dilution series in DMSO were prepared in Echo Qualified 384-well Polypropylene Micr...More data for this Ligand-Target Pair
